Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Co-administrated BR1018B and BR1018C [Phase 3]

View source ↗

Summary

The document reports the completion of a Phase 3 clinical trial evaluating the efficacy and safety of co-administered BR1018B and BR1018C. The study targeted es…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension
• Hypercholesterolemia

Drugs mentioned

• BR1018B
• BR1018C

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Essential Hypertension, Primary Hypercholesterolemia | Phase 3 | Status: COMPLETED